Intensity Therapeutics, Inc. (INTS) Open Interest History

Open interest tracks the total number of outstanding options contracts. Rising OI alongside price moves can indicate growing commitment to the trend; declining OI suggests positions are being closed.

Intensity Therapeutics, Inc. (INTS) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $8.4M, listed on NASDAQ, employing roughly 5 people, carrying a beta of 3.26 to the broader market. Intensity Therapeutics, Inc. Led by Lewis H. Bender, public since 2023-06-30.

Open interest history tracks how outstanding options contracts change over time. No recent options activity for INTS as of 2026-06-01; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how open interest is reported and how to read the data →